Palisade Bio
PALI
6 hedge funds and large institutions have $6.08M invested in Palisade Bio in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
500% more call options, than puts
Call options by funds: $18K | Put options by funds: $3K
50% more funds holding
Funds holding: 4 → 6 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
41% less capital invested
Capital invested by funds: $10.4M → $6.08M (-$4.31M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.18M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$530K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$530K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$530K |
| 2 |
IGIM
I.G. Investment Management
Winnipeg,
Manitoba, Canada
|
-$347K |
| 3 |
Millennium Management
New York
|
-$183K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$18K |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
-$18K |
PALI Hedge Fund Activity: Q2 2016 in Review
6 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2016, worth a combined $6.08M — down 41% from $10.4M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PALI positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $3.18M. The largest seller was Putnam Investments, cutting an estimated $530K.
- 6 institutional investors held Palisade Bio (PALI) as of Q2 2016, up from 4 in Q1 2016.
- Funds reported $6.08M of Palisade Bio stock for Q2 2016, down 41% quarter-over-quarter.
- 2 funds opened new Palisade Bio positions in Q2 2016 and 0 closed out, a net change of +2 holders.
- The largest Palisade Bio buyer in Q2 2016 was Sabby Management, an estimated $3.18M added.
- The largest Palisade Bio seller in Q2 2016 was Putnam Investments, an estimated $530K sold.
Based on aggregated 13F filings for Q2 2016.